DCM-SR
DCM-SR contains dexchlorpheniramine maleate, an antihistamine that provides relief from allergic symptoms by blocking the effects of histamine, a substance in the body that causes allergic reactions. The sustained-release formulation ensures prolonged effects, offering extended relief from allergy symptoms with fewer doses throughout the day.
- Recommended Usage
Indication
- Seasonal allergic rhinitis (hay fever)
- Perennial allergic rhinitis
- Allergic conjunctivitis (itchy or watery eyes)
- Urticaria (hives)
- Sneezing and runny nose due to colds or upper respiratory infections
Dosage and Administration
Route of Administration: Oral sustained-release tablet.
Typical dose for adults and children over 12 years: 6 mg once or twice daily, depending on the severity of symptoms.
Children aged 6-12 years: 3 mg once or twice daily.
Elderly or patients with liver or kidney impairment: Consult a healthcare provider for dose adjustments.
Precautions
Avoid use in patients with known hypersensitivity to dexchlorpheniramine or any component of the tablet.
Use caution in patients with a history of glaucoma, asthma, or urinary retention.
Not recommended for use in patients with severe liver or kidney impairment without medical advice.
May cause drowsiness, dizziness, or dry mouth.
Avoid alcohol, as it may increase sedative effects.
Not recommended during pregnancy or breastfeeding unless prescribed by a doctor.
Contraindications
Hypersensitivity to dexchlorpheniramine maleate or any excipient in the tablet.
Acute narrow-angle glaucoma.
Severe urinary retention or enlarged prostate.
Key Benefits
Sustained Relief: The sustained-release formulation provides long-lasting relief from allergy symptoms, reducing the need for frequent dosing.
Effective for Multiple Conditions: Relieves symptoms of allergic rhinitis, allergic conjunctivitis, hives, and cold-related symptoms.
Convenient Dosage: Once or twice-daily dosage provides convenience and ease of use.
Reduced Sedation: While drowsiness may occur, the sustained release helps minimize this effect compared to immediate-release formulations.
Improved Quality of Life: Helps manage allergy symptoms effectively, allowing patients to maintain daily activities without discomfort.
